Are cannabinoids a new treatment option for pain in patients with fibromyalgia?

Nature Clinical Practice Rheumatology

Volumn 4, Issue 7, 2008, Pages 348-349

  Staud, Roland ^a   Koo, Eubee B ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; DRONABINOL; NABILONE; PLACEBO;

ANALGESIA; ANXIETY; ARTICLE; ATAXIA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; DROWSINESS; DRUG RECEPTOR BINDING; EVENING DOSAGE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; HUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; VERTIGO; VISUAL ANALOG SCALE; XEROSTOMIA;

EID: 47149095429     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0826     Document Type: Article

References (7)

1. Crofford LJ et al. (2005) Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52: 1264-1273
2. Staud R and Rodriguez ME (2006) Mechanisms of Disease: Pain in fibromyalgia syndrome. Nat Clin Pract Rheumatol 2: 90-98
3. Ashton JC and Milligan ED (2008) Cannabinoids for the treatment of neuropathic pain: Clinical evidence. Curr Opin Investig Drugs 9 65-75
4. Lutz B (2002) Molecular biology of cannabinoid receptors. Prostaglandins Leukot Essent Fatty Acids 66: 123-142
5. Marsicano G and Lutz B (2006) Neuromodulatory functions of the endocannabinoid svstem. J Endrocrinol Inves 29 (Suppl 3): 27-46
6. Rukwied R et al. (2003) Cannabinoid agonists attenuate capsaicin-induced responses in human skin. Pain 102: 283-288
7. Agarwal N et al. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10: 870-879